Tower Research Capital LLC (TRC) - PHARMACYTE BIOTECH INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PHARMACYTE BIOTECH INC
ValueSharesWeighting
Q3 2023$2,558
+255700.0%
1,218
+141.2%
0.00%
Q1 2023$10.0%505
+144.0%
0.00%
Q4 2022$1207
+113.4%
0.00%
Q3 2022$0
-100.0%
97
-91.6%
0.00%
Q2 2022$2,0000.0%1,161
+78.6%
0.00%
Q4 2021$2,000
-90.9%
650
-90.8%
0.00%
-100.0%
Q3 2021$22,0007,0700.00%
Other shareholders
PHARMACYTE BIOTECH INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ayrton Capital LLC 1,033,130$3,027,0718.27%
K2 PRINCIPAL FUND, L.P. 732,105$2,145,0680.33%
EQUITEC PROPRIETARY MARKETS, LLC 330,694$968,9330.31%
SABBY MANAGEMENT, LLC 97,978$287,0760.25%
FNY Investment Advisers, LLC 31,100$900.13%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 40,800$119,5440.02%
Aspire Private Capital, LLC 800$2,3440.00%
Schonfeld Strategic Advisors LLC 25,200$73,8360.00%
OSAIC HOLDINGS, INC. 1,758$6,0000.00%
BANK OF AMERICA CORP /DE/ 98$2860.00%
View complete list of PHARMACYTE BIOTECH INC shareholders